Meacor logo
Meacor logo

Meacor

meacor.com
meacor.com • Series A 2024 • Startup • New
Series A 2024 • Startup • New
Actively hiring
As featured in
Yahoo Finance
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$15M
1 round on record
Latest round
$15M
Series A · May 2024 · 2 yr ago
Backers
2
IM Fndng, MEVP
The money's age
Long since its last round
28 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 14, 2024 Raised a round Series A $15M · YahooFinance
Funding rounds
RoundDateAmountInvestorsSource
Series A May 2024 $15M — YahooFinance
Backed byfrom the funds' portfolios and accelerator catalogs
IM Fndng fund MEVP fund
Investors in similar startupsfunds that back the companies most like this one
Longitude Capital
backs Polares Medical
Band of Angels
backs Atraverse Medical
Industrifonden
backs HVR Cardio
Karista
backs TRiCares GmbH
Gopher Angels
backs Atraverse Medical
Endeavour Vision
backs Polares Medical
Similar startupsby what they do, their industry and backers
TRiCares GmbHSeries D $50M · 2 yr ago • 11-50 employees
Our Mission TRiCares' mission is to revolutionize the treatment of tricuspid regurgitation (TR). We are developing Topaz, a minimally…
Versa VascularSeries C $27.3M · 11 mo ago • Founded 2020
Innovating Valve Repair. Versa Vascular is leading development of a novel tricuspid valve repair solution in Santa Cruz, California.
Polares MedicalSeries C $50M · 7 mo ago • 201-500 employees
— Reshaping treatment for Functional Mitral Regurgitation (FMR) Transcatheter Leaflet Restoration (TLR) system is engineered to work in…
BiVACORVenture round $9M · 2 yr ago • 51-200 employees • 7 roles
Replacing Hearts. Restoring Lives. HEART FAILURE Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2…
HVR CardioSeries B $11M · 3 yr ago • Founded 2009 • 11-50 employees
HVR Cardio is a cardiovascular device company developing breakthrough solutions for mitral valve repair based on its proprietary HELIX…
PacertoolFounded 2020 • 1-10 employees
Pacertool develops PaCRTool, a highly differentiated and proprietary solution to improve cardiac resynchronization therapy (CRT) in heart…

Overview

Striving For Healthier Hearts. Mitral and Tricuspid valve regurgitation are a serious medical condition in which the valves leak blood backward. If left untreated, it eventually leads to heart failure.

News

News YahooFinance 2 years ago
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repair Technology
BOSTON, May 14, 2024 (GLOBE NEWSWIRE) -- MEACOR Inc. is pleased to announce the successful closing of its $15 million Series A funding round. This substantial investment supports MEACOR's mission to offer a novel transcatheter approach for the treatment o
Read more
Report
Blog 5 years ago
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Read more
Report

Financials

Total raised
$15M
Latest round
Series A
Funding rounds
1
Funding rounds
Round Announced Amount
Series A 2024 $15M Details